Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Hillary V. Kunins"'
Publikováno v:
Harm Reduction Journal, Vol 17, Iss 1, Pp 1-7 (2020)
Abstract Background Recent research shows an increase in drug and alcohol-related hospitalizations in the USA, especially among older adults. However, no study examines trends in discharges to a skilled nursing facility (SNF) after a drug or alcohol-
Externí odkaz:
https://doaj.org/article/d2da30299e04418384f351396bec7206
Autor:
Jennifer McNeely, Andrea B. Troxel, Hillary V. Kunins, Donna Shelley, Joshua D. Lee, Alexander Walley, Zoe M. Weinstein, John Billings, Nichola J. Davis, Roopa Kalyanaraman Marcello, Bruce R. Schackman, Charles Barron, Luke Bergmann
Publikováno v:
Addiction Science & Clinical Practice, Vol 14, Iss 1, Pp 1-12 (2019)
Abstract Background Treatment for opioid use disorder (OUD) is highly effective, yet it remains dramatically underutilized. Individuals with OUD have disproportionately high rates of hospitalization and low rates of addiction treatment. Hospital-base
Externí odkaz:
https://doaj.org/article/1ca1b83fa3f5486586974d110f53af74
Publikováno v:
Journal of the American Pharmacists Association. 63:885-892
Autor:
Hillary V. Kunins, Sabina Saleh, Ellenie Tuazon, Jessica A. Kattan, Christian Jimenez, Marissa Kaplan-Dobbs
Publikováno v:
Am J Public Health
The Buprenorphine Nurse Care Manager Initiative (BNCMI) sought to increase access to opioid use disorder treatment in underserved New York City populations by expanding buprenorphine treatment capacity in safety-net primary care clinics. During 2016
Autor:
Hillary V. Kunins
Publikováno v:
Journal of Public Health Management and Practice. 26:201-205
Autor:
Alice E. Welch, Bruce R. Schackman, Hillary V. Kunins, Jennifer Dolatshahi, Czarina N Behrends, Sarah Gutkind, Emily Winkelstein, Denise Paone, Monique Wright
Publikováno v:
Subst Abus
BACKGROUND: Naloxone is an opioid antagonist medication that can be administered by lay people or medical professionals to reverse opioid overdoses and reduce overdose mortality. Cost was identified as a potential barrier to providing expanded overdo
Publikováno v:
Am J Public Health
Relay, a peer-delivered response to nonfatal opioid overdoses, provides overdose prevention education, naloxone, support, and linkage to care to opioid overdose survivors for 90 days after an overdose event. From June 2017 to December 2018, Relay ope
Publikováno v:
Pharmacoepidemiol Drug Saf
Purpose To evaluate New York State's mandate that prescribers query the prescription drug monitoring program (PDMP) prior to prescribing Schedule II-IV medications. Methods We conducted an interrupted time series analysis of opioid analgesic prescrip
Autor:
Frederick W. Nagel, Denise Paone, Hillary V. Kunins, Lewis S. Nelson, Shivani Mantha, Jessica A. Kattan
Publikováno v:
Journal of Public Health Management and Practice. 24:306-309
To address the epidemic of opioid misuse and overdose, the New York City Department of Health and Mental Hygiene partnered with an expert panel of emergency medicine physicians to develop voluntary guidelines for judicious prescribing of opioids upon
Publikováno v:
Substance Abuse. 39:233-238
Background Overdose deaths tripled between 1999 and 2014. Most fatal overdoses are witnessed, offering an opportunity for bystanders to call 911. However, fear of arrest may prevent them from calling authorities. Many states have passed 911 Good Sama